Summit Therapeutics' leading candidate is showing promise in a key oncology market. Three years ago, Summit Therapeutics ...

Sarepta Therapeutics has rejected a call by the Food and Drug Administration to stop shipments of its muscular dystrophy drug.

On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster ...

Shares of Viking Therapeutics soared last year on high hopes for its obesity drug VK2735. The stock stumbled beginning in ...

Mounjaro suppresses the appetite of the user, as well as increases their sense of fullness, by activating two receptors ...

Novo Nordisk's U.S.-listed shares fell close to 6% Monday after the drugmaker revealed the latest results for a new ...

Anthem Biosciences Ltd's shares debuted with a 27% premium over the issue price, initially trading at Rs 723.10 on the BSE.

UCSF researchers find that two FDA-approved cancer drugs significantly improve memory in Alzheimer’s mouse models and reduce ...

Researchers followed 60,000 adults aged 40 and older—who took various types of antidiabetic medication—for seven years ...

Saliva is ace because it neutralises acid, washes away food particles and remineralises tooth enamel - the latter of which ...

Johnson & Johnson has delivered excellent returns to its long-term shareholders. Case in point: Shares of Johnson & Johnson ...

Johnson & Johnson reported second-quarter results on July 16. Sales of pharmaceuticals have been muted due to a loss of ...